TruSight Oncology Comprehensive
DNA/RNA comprehensive genomic profiling assay for solid tumors with indication-specific companion-diagnostic claims.
- Developer
- Illumina
- Intended use
- Other
- Cancer scope
- Not reported
- Specimen
- FFPE tumor tissue
- Molecular modality
- DNA mutation, RNA
- Current version
- TruSight Oncology Comprehensive — P230011/S006 configuration
- Evidence context
- 1 structured studies · 2 indexed performance results · 4 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.